OTCMKTS:LHDXQ Lucira Health (LHDXQ) Stock Price, News & Analysis → The Long-Awaited End of America Update (From Stansberry Research) (Ad) Free LHDXQ Stock Alerts $0.0001 +0.00 (+∞) (As of 10/4/2023) Add Compare Share Share Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.00▼$1.45Volume20,900 shsAverage Volume7.18 million shsMarket Capitalization$4,060.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisInsider TradesStock AnalysisInsider Trades Get Lucira Health alerts: Email Address Ad Stansberry ResearchUrgent dollar warningYour 2024 Election Money Blueprint Voters are angrier than ever, and it's likely to keep getting worse. The media and Wall Street keep declaring how great the economy supposedly is... but no one – besides the ultra-rich – seems to feel that way. Protect yourself with this one simple move today.Find out for free here. About Lucira Health Stock (OTCMKTS:LHDXQ)Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California. On February 22, 2023, Lucira Health, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.Read More LHDXQ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LHDXQ Stock News HeadlinesSeptember 20, 2023 | msn.comU.S. govt. to restart program to ship free at-home COVID testsAugust 3, 2023 | forbes.comBest Senior Dating Sites Of 2023May 2, 2024 | Stansberry Research (Ad)Urgent dollar warningYour 2024 Election Money Blueprint Voters are angrier than ever, and it's likely to keep getting worse. The media and Wall Street keep declaring how great the economy supposedly is... but no one – besides the ultra-rich – seems to feel that way. Protect yourself with this one simple move today.April 28, 2023 | benzinga.comRemember Lucira Health's 30 Minute Home Test Kit? Pfizer Just Bought the Bankrupt Company Via Winning Auction BidApril 20, 2023 | marketwatch.com8-K: Lucira Health, Inc.April 11, 2023 | bizjournals.comBankruptcy court bidder for Covid-flu test maker Lucira objects to planned sale to PfizerApril 7, 2023 | bizjournals.comPfizer to buy Covid-flu test developer Lucira Health out of bankruptcy courtApril 6, 2023 | wsj.comFirm Retention Summary: Lucira Health Inc.May 2, 2024 | Stansberry Research (Ad)Urgent dollar warningYour 2024 Election Money Blueprint Voters are angrier than ever, and it's likely to keep getting worse. The media and Wall Street keep declaring how great the economy supposedly is... but no one – besides the ultra-rich – seems to feel that way. Protect yourself with this one simple move today.March 29, 2023 | marketwatch.comLucira Health Announces U.S. Launch of First & Only At-Home Combination COVID-19 & Flu Test Amidst Sale ProcessMarch 20, 2023 | investing.comLucira Health Inc (LHDXQ)March 18, 2023 | finance.yahoo.comFDA Addresses 'Misinformation' Concerning Delayed Approval Of Lucira Health's COVID-19 & Flu Home TestMarch 17, 2023 | seekingalpha.comLHDXQ Lucira Health, Inc.March 10, 2023 | finance.yahoo.comFDA Addresses 'Misinformation' Concerning Delayed Approval Of Lucira Health's COVID-19 & Flu Home TestMarch 8, 2023 | bizjournals.comCovid-flu test fell short of number of flu samples, FDA says in explaining delayMarch 8, 2023 | bizjournals.comFDA fires back at claims of long delay in approving combined Covid-flu testMarch 7, 2023 | finance.yahoo.comUPDATE 1-Lucira's home test for flu and COVID-19 gets U.S. FDA nod for OTC useMarch 7, 2023 | finance.yahoo.comFDA Approval Brings Some Good News For Bankrupt Lucira HealthMarch 3, 2023 | investorplace.comWhy Is Lucira Health (LHDX) Stock Down 14% Today?February 28, 2023 | benzinga.comShort Volatility Alert: Lucira Health IncFebruary 28, 2023 | msn.comLucira Soars on FDA Approval of COVID-19 and Flu TestFebruary 27, 2023 | finance.yahoo.comLucira Health Announces FDA Authorization of First & Only At-Home Combination Covid-19 & Flu Test and Comments on Chapter 11 Bankruptcy FilingFebruary 27, 2023 | msn.comLucira Health is Soaring Monday: Here Are The DetailsFebruary 27, 2023 | rttnews.comFDA Authorizes First At-Home Test To Detect Flu And COVID-19 February 24, 2023 | bizjournals.comDelay with Covid-flu test sent East Bay company to Chapter 11. Regulators OK it — two days laterFebruary 24, 2023 | finance.yahoo.comLucira stock more than doubles after hours on FDA OK for COVID-19, flu testFebruary 24, 2023 | seekingalpha.comLucira Health to sell business and file Chapter 11 bankruptcy; shares down 7%See More Headlines Receive LHDXQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lucira Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/11/2021Today5/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostic substances Sub-IndustryN/A Current SymbolOTCMKTS:LHDXQ CUSIPN/A CIK1652724 Webwww.lucirahealth.com Phone510-350-8071FaxN/AEmployees221Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$93.06 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$4.81 per share Price / Book0.00Miscellaneous Outstanding Shares40,600,000Free Float28,257,000Market Cap$4,060.00 OptionableNot Optionable Beta2.60 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesGreg ChodaczekInvestor RelationsDr. Nadine Greiner Ph.D.Chief HR OfficerKey CompetitorsGlobal WholeHealth PartnersOTCMKTS:GWHPKaleido BiosciencesNASDAQ:KLDORBC Life SciencesOTCMKTS:RBCLSkylight Health GroupOTCMKTS:SLHGFSophiris BioOTCMKTS:SPHSView All Competitors LHDXQ Stock Analysis - Frequently Asked Questions How have LHDXQ shares performed in 2024? Lucira Health's stock was trading at $0.0001 at the beginning of 2024. Since then, LHDXQ stock has increased by 0.0% and is now trading at $0.0001. View the best growth stocks for 2024 here. How were Lucira Health's earnings last quarter? Lucira Health, Inc. (OTCMKTS:LHDXQ) issued its quarterly earnings results on Thursday, November, 11th. The company reported ($0.47) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.51) by $0.04. The company had revenue of $14.98 million for the quarter, compared to analyst estimates of $18 million. How do I buy shares of Lucira Health? Shares of LHDXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:LHDXQ) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceDollar CancelledLear CapitalRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucira Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
